| oxolinic acid |
![]() |
Environmental Fate - Ecotoxicology - Human Health
- A to Z Index
- Home
Further data may be found in the VSDB
Description: An antibacterial drug used to treat urinary tract and other infections. Also shows activity against plant-pathogenic bacteria
Introduction: 1989, first introduced Japan
EC Directive 1107/2009 (repealing 91/414):
| Status | Not applicable |
| Dossier rapporteur/co-rapporteur | Not applicable |
| Date inclusion expires | Not applicable |
Approved for use (
) or known to be used (
) in the following European countries:
AT |
BE |
BG |
CY |
CZ |
DE |
DK |
EE |
EL |
ES |
FI |
FR |
HU |
IE |
IT |
LT |
LU |
LV |
MT |
NL |
PL |
PT |
RO |
SE |
SI |
SK |
UK |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pesticide type | Veterinary treatment; Fungicide | |||
| Substance group | Quinolone | |||
| Substance origin | Synthetic | |||
| Mode of action | Works via two routes, by inhibiting the enzyme DNA gyrase and also acts as a dopamine reuptake inhibitor. | |||
| CAS RN | 14698-29-4 | |||
| EC number | 238-750-8 | |||
| CIPAC number | - | |||
| US EPA chemical code | - | |||
| Chemical formula | C13H11NO5 | |||
| SMILES | c12c(cc3OCOc3c2)c(c(C(O)=O)cn1CC)=O | |||
| International Chemical Identifier (InChI) | InChI=1/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17) | |||
| Structure diagram/image available? | Yes | |||
| Molecular mass (g mol-1) | 261.23 | |||
| IUPAC Name | 5-ethyl- 8-oxo- 5,8-dihydro [1,3] dioxolo [4,5-g] quinoline- 7-carboxylic acid | |||
| CAS Name | 5-ethyl-5,8-dihydro-8-oxo-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid | |||
| Other status information | Annex 1 EC Reg. 2377/90 | |||
| Herbicide Resistance Classification (HRAC) | Not applicable | |||
| Insecticide Resistance Classification (IRAC) | Not applicable | |||
| Fungicide Resistance Classification (FRAC) | Not applicable | |||
| Physical state | White to pale yellow crystalline solid | |||
| Related substances & organisms | ||||
Formulations:
Degradation:
Soil adsorption and mobility:
Property ![]() |
Value | Source/Quality Score/Other Information ![]() |
Interpretation ![]() |
|
| Linear | Kd | - | - | - |
| Koc | - | |||
| Notes and range | - | |||
| Freundlich | Kf | - | - | - |
| Kfoc | - | |||
| 1/n | - | |||
| Notes and range | - | |||
| pH sensitivity | - | |||
Other known metabolites:
| Metabolite name and reference | Aliases | Formation Medium / Rate | Estimated Maximum Occurrence Fraction | Metabolising Enzymes |
| 1-ethyl-1,4-dihydro-7-hydroxy-6-methoxy-6-oxoquinoline-3-carboxylic acid | - | Rat, Rabbit, Dog | - | - |
| Oxolinoyl-beta-D-glucuronic acid Note: Active metabolite |
- | Rat (Uriinary), Rabbit (Urinary), Dog (Urinary) | - | - |
| 5-ethyl-5,8-dihydro-8-oxo-1,3-dioxolo-[4,5,g]quinoline-7-carboxylic acid | - | Human | - | - |
| - | - | - | - | - |
General:
Property ![]() |
Value | Source/Quality Score/Other Information ![]() |
Interpretation ![]() |
|
| Mammals - Acute oral LD50 (mg kg-1) | > 525 | A5 Rat | Moderate | |
| Mammals - Dermal LD50 (mg kg-1 body weight) | > 2000 | Q3 Rat | - | |
| Mammals - Inhalation LC50 (mg l-1) | - | - | - | |
| Other Mammal toxicity endpoints | Intravenous LD50 = 177 mg kg-1 | V3 Mice | - | |
| ADI - Acceptable Daily Intake (mg kg-1bw day-1) | - | - | - | |
| ARfD - Acute Reference Dose (mg kg-1bw day-1) | - | - | - | |
| AOEL - Acceptable Operator Exposure Level - Systemic (mg kg-1bw day-1) | - | - | - | |
| Dermal penetration studies (%) | - | - | - | |
| Dangerous Substances Directive 76/464 | - | - | - | |
| Exposure Limits | - | - | - | |
| Exposure Routes | Public | - | ||
| Occupational | - | |||
| Examples of European MRLs (mg kg-1) | Value | - | ||
| Note | For the EU pesticides database click here | |||
| Drinking Water MAC (µg l-1) | - | - | - | |
Health issues:
| Carcinogen | Mutagen | Endocrine disrupter | Reproduction / development effects | Acetyl cholinesterase inhibitor | Neurotoxicant | Respiratory tract irritant | Skin irritant | Eye irritant |
|
- |
- |
- |
- |
|
|
|
|
| General human health issues | [Harmfull if swallowed], [May cause visual disturbances, fever, anorexia, urticaria, and photosensitivity reactions], [May cause gastrointestinal tract problems] | |||||||
: Yes, known to cause a problem
: No, known not to cause a problem
: Possibly, status not identified
- : No data
Handling issues:
| Language | Name |
| English | oxolinic acid |
| French | acide oxolinique |
| German | - |
| Danish | - |
| Italian | - |
| Spanish | acido oxolinico |
| Greek | - |
| Slovenian | - |
| Polish | - |
| Swedish | - |
| Hungarian | - |
| Dutch | - |
| Record last updated: Monday 26 December 2011 Contact: aeru@herts.ac.uk |